Cancer Genetics, Inc. said thursday that it has priced its initial public offering of 600,000 shares of its common stock at a price to the public of $10.00 per share, which is at the low end of it previous expected range of $10.00 to $12.00 per share.

The gross proceeds to Cancer Genetics from the initial public offering are expected to be $6 million, assuming no exercise of the over-allotment option, before underwriting discounts and commissions and other offering expenses payable by Cancer Genetics.

Cancer Genetics has granted the representative of the underwriters a 45-day option to purchase up to 90,000 additional shares of common stock from the company to cover over-allotments, if any.

Shares of Cancer Genetics' common stock are expected to be quoted on the OTCQB Marketplace, operated by OTC Markets Group, under the symbol "CGIX" beginning on April 5, 2013.

Click here to receive FREE breaking news email alerts for Cancer Genetics, Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Read the original post:
Cancer Genetics Prices IPO At Low End Of Range

Comments are closed.